BUPRENORPHINE MARKET ANALYSIS

Regional Analysis

Global Buprenorphine Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global buprenorphine market over the forecast period. North America holds 45.1% of the market share due to the increasing prescriptions of buprenorphine in the region. For instance, according to an article published by the American Medical Association in January 2020, buprenorphine is seen as having the best chance of increasing access among the drugs that the US Food and Drug Administration has licensed for treating opioid use disorder. In the US, estimates of office visits containing prescriptions for buprenorphine increased from 1.9 million to 4.3 million between 2009 and 2018.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa